(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
...
Evaxion Biotech (EVAX) will use Personalis's (PSNL) ImmunoID NeXT platform in a phase 2b trial to assess the efficacy and safety of its EVX-01 personalized...
| Address | 1330 O'Brien Drive Menlo Park, California 94025 |
| Phone | +1.650.752.1300 |
| Number of Employees | 139 |
| President, Chief Executive Officer & Director | John S. West |
| Chief Financial Officer & Senior Vice President | Aaron Tachibana |
| Chief Medical Officer, SVP-Research & Development | Richard O. Chen |
| Vice President-Immunology, Research & Development | Xavier Paliard |
| Price Open | $4.95 |
| Previous Close | $4.80 |
| 52 Week Range | $3.97 - 28.47 |
| Market Capitalization | $218.6 M |
| Shares Outstanding | 45.4 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 08/03/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$1.81 |
| Beta vs. S&P 500 | N/A |
| Revenue | $37.8 M |
| Net Profit Margin | -101.49% |
| Return on Equity | -25.70% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
